J&J Talc Settlement and Ovarian Cancer Lawsuit: 2026 Status and Who Qualifies

The lawsuits claim that regular use of talc powder in the genital area, from products such as Johnson's Baby Powder and Shower to Shower, can cause ovarian cancer, and that Johnson & Johnson knew about the risk and did not warn women. A second group of cases claims the talc was contaminated with asbestos and caused mesothelioma, a cancer of the lining of the lungs or abdomen.

The federal ovarian cancer cases are consolidated as In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, MDL No. 2738, in the U.S. District Court for the District of New Jersey (case 3:16-md-02738). Thousands more cases are in state courts in places like California, Missouri, and Pennsylvania.

The companies involved

• Johnson & Johnson: the maker of Johnson's Baby Powder, which says its talc is safe and asbestos free.
• LTL Management and Red River Talc: subsidiaries J&J created to hold talc liability and put into bankruptcy. All three bankruptcy attempts were dismissed.
• Kenvue: J&J's former consumer health business, which now sells the brand; J&J has kept responsibility for talc claims in the U.S. and Canada.

J&J stopped selling talc-based baby powder in the U.S. in 2020 and switched to cornstarch. If you used the product before then, the switch does not affect your claim.

The federal cases are pending before U.S. District Judge Michael A. Shipp in New Jersey. As of September 1, 2026, 69,250 talc lawsuits were pending in MDL 2738, making it the largest active multidistrict litigation in the country.

The bankruptcy detour

The litigation was paused for more than three years while J&J tried to resolve talc claims through the bankruptcy of a subsidiary, a strategy known as the Texas two-step. On March 31, 2025, Judge Christopher Lopez in Houston rejected the Red River Talc bankruptcy, ending a proposed settlement worth about $8 billion. J&J said it would not appeal and would return to fighting cases in court.

Expert fights and the July 2026 ruling

In early 2026, a special master, retired Judge Freda Wolfson, recommended that juries be allowed to hear plaintiffs' experts on whether talc can cause ovarian cancer. After plaintiffs withdrew two experts following a May 2026 hearing, J&J asked the court to dismiss the cases, and on July 22, 2026 the court ordered plaintiffs to show why their claims should not be dismissed for lack of proof that talc caused each woman's cancer.

The $5.5 billion deal

Days later, on July 27, 2026, J&J announced the proposed settlement. According to Reuters, the deal covers about 76,000 ovarian cancer claims in federal and state courts, J&J expects to pay $3 billion in 2027 with further payments in 2028, and the settlement assigns values to qualifying claims without capping J&J's total payout. By late August 2026, plaintiffs' lawyers told the court they were registering claimants, and most MDL work was paused to focus on the settlement.

Recent trials

Trial results have been mixed. A California state jury awarded $40 million to two women with ovarian cancer in December 2025, and a Philadelphia jury awarded $250,000 to a family in February 2026, while J&J won a defense verdict in a second California ovarian cancer trial in 2026.

Attorneys who handle these cases generally look for four things:

1. A qualifying diagnosis: epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed by pathology.
2. Regular use: genital use of Johnson's Baby Powder or Shower to Shower, often for years, such as daily dusting of underwear, sanitary pads, or the perineal area.
3. Timing: the talc use came before the diagnosis.
4. Filing status: the proposed settlement covers existing claims, so whether you have already filed matters a great deal.

If you have already filed

Your lawyer should contact you about the settlement terms, the value assigned to your claim, and the deadline to accept. The deal only takes effect if at least 95% of eligible ovarian cancer claimants participate, so each claimant's decision matters.

If you have not filed

According to Reuters, the agreement applies only to existing claims and does not address future lawsuits. A woman diagnosed recently may still be able to bring an individual case, but it would sit outside the settlement, and J&J will argue the same causation defenses it has raised in the MDL.

Who probably does not qualify

Women who used talc only rarely, used it only on other parts of the body, or have a cancer type the science does not link to talc, such as some non-epithelial ovarian tumors, face weak claims. Mesothelioma cases are a different track, covered on our mesothelioma and asbestos lawsuit page.

No official per-person amount has been published. What is known from reporting on the deal:

Simple division gives a rough sense of scale: $5.5 billion spread over 76,000 claims is about $72,000 per claim before attorney fees and costs. Real payments will not be equal. Plaintiffs' co-lead counsel Chris Seeger told Reuters the settlement assigns specific values to qualifying claims and that J&J's total could reach $7 billion or more depending on participation. Claims with stronger medical records, longer use, and more severe outcomes are likely to be valued higher, and contingency fees commonly take a third or more of each award.

Past talc verdicts for context

• Before the bankruptcy attempts, a Missouri jury returned a multibillion dollar verdict for 22 women who said baby powder caused their ovarian cancer; other J&J verdicts were reduced on appeal.
• A California jury awarded $40 million to two women in December 2025.
• A Philadelphia jury awarded $250,000 in February 2026.

Verdicts are not a reliable guide to settlement values. Settlements trade a lower, certain payment for avoiding years of trials and appeals. For how mass tort settlements differ from class actions, see class action vs. mass tort.

Talc cases are individual product liability lawsuits, not a class action. Each woman must prove her own case. The main claims are:

• Failure to warn: J&J allegedly knew of studies linking genital talc use to ovarian cancer and did not put a warning on the label.
• Design defect: a safer alternative, cornstarch, was available.
• Negligence and fraud: claims that J&J misrepresented talc's safety in marketing.

General and specific causation

Plaintiffs must prove two things: that talc can cause ovarian cancer in general, and that it caused this particular woman's cancer. The July 22, 2026 show cause order was about the second question. Without a qualified expert to tie talc to each woman's cancer, a court can dismiss the case even if the general science is allowed in.

J&J's defense also relied for decades on published safety literature. In 2026, The Lancet retracted a 1977 commentary on cosmetic talc safety after editors learned its author had been a J&J consultant, a fact not disclosed at publication.

Every state sets a statute of limitations for personal injury and wrongful death. Most states give 2 to 3 years to file a personal injury case, often counted from when you learned or reasonably should have learned that your cancer may be linked to talc. Some states allow less time, and wrongful death deadlines usually run from the date of death.

The settlement process has its own deadlines. Claimants who have already filed will receive the terms and a date to accept or decline. If you miss that date, your case may be treated as a non-participant, which can mean continuing in litigation rather than getting paid in 2027.

Because the talc warnings have been widely publicized for years, J&J may argue that deadlines started running long ago. Talk to an attorney before assuming you still have time.

If you have a pending talc case, your lawyer will present the settlement terms and ask you to decide. Because the deal only works if 95% of eligible claimants participate, you may feel pressure to sign quickly. It is reasonable to ask questions first.

• How was my claim valued? Ask which tier or category your case falls into and what records put it there.
• What is the gross and net amount? Ask for the estimated award, the fee percentage, case costs, and any common benefit assessment.
• Are there liens? Medicare, Medicaid, and private insurers that paid for cancer treatment may have a right to be repaid from the award.
• When will I be paid? Reuters reported payments of about $3 billion in 2027 and the rest in 2028; ask when your share is expected.
• What happens if I say no? Ask whether your case would go back to litigation, and how the July 2026 causation ruling could affect it.

A family member acting for someone who has died may need to open an estate before signing. Keep copies of everything you sign.

1. If you have a lawyer: ask for the settlement terms in writing, the value assigned to your claim, the fee percentage, any liens (Medicare, Medicaid, or health insurers may seek repayment), and the deadline to accept.
2. If you do not have a lawyer: gather your pathology report and treatment records, and write down when and how you used talc products.
3. Watch for scams. The settlement is administered through the court process and claimants' lawyers. No one legitimate will charge an upfront fee to add you to it.
4. Do not sign anything from J&J or an insurer without legal advice.

For how these consolidated cases move, read what an MDL is and how long these cases take. We also track the J&J talc settlement separately. A free case review takes about two minutes and can connect you with independent attorneys who handle talc cases. Related: hair relaxer cancer lawsuits.